JPH11510505A5 - - Google Patents
Info
- Publication number
- JPH11510505A5 JPH11510505A5 JP1997508246A JP50824697A JPH11510505A5 JP H11510505 A5 JPH11510505 A5 JP H11510505A5 JP 1997508246 A JP1997508246 A JP 1997508246A JP 50824697 A JP50824697 A JP 50824697A JP H11510505 A5 JPH11510505 A5 JP H11510505A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9516287.1 | 1995-08-09 | ||
| GB9516287A GB2304047A (en) | 1995-08-09 | 1995-08-09 | Pharmaceutical compositions containing cytokines |
| PCT/GB1996/001930 WO1997005894A1 (en) | 1995-08-09 | 1996-08-08 | Pharmaceutical composition containing il-10 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH11510505A JPH11510505A (ja) | 1999-09-14 |
| JPH11510505A5 true JPH11510505A5 (enExample) | 2004-09-09 |
| JP4050317B2 JP4050317B2 (ja) | 2008-02-20 |
Family
ID=10778967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50824697A Expired - Fee Related JP4050317B2 (ja) | 1995-08-09 | 1996-08-08 | Ｉｌ−１０含有医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6387364B1 (enExample) |
| EP (1) | EP0871473B1 (enExample) |
| JP (1) | JP4050317B2 (enExample) |
| AT (1) | ATE229814T1 (enExample) |
| AU (1) | AU719089B2 (enExample) |
| CA (1) | CA2229078C (enExample) |
| DE (1) | DE69625516T2 (enExample) |
| DK (1) | DK0871473T3 (enExample) |
| ES (1) | ES2187665T3 (enExample) |
| GB (1) | GB2304047A (enExample) |
| PT (1) | PT871473E (enExample) |
| WO (1) | WO1997005894A1 (enExample) |
| ZA (1) | ZA966744B (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0941108T3 (da) * | 1996-12-04 | 2002-11-18 | Renovo Ltd | Sårheling og behandling af fibrose |
| AU6045198A (en) * | 1997-02-05 | 1998-08-25 | Schering Corporation | Use of il-4 and/or il-10 to treat proliferative glomerulonephritis |
| WO2001017558A2 (en) * | 1999-09-08 | 2001-03-15 | Schering Corporation | Novel uses of mammalian ccr6 receptors and related reagents |
| US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
| WO2002026265A2 (en) | 2000-09-29 | 2002-04-04 | Schering Corporation | Pegylated interleukin-10 |
| AU2002365261A1 (en) * | 2001-10-18 | 2003-09-02 | The Children's Hospital Of Philadelphia | Methods and materials for the recruitment of endothelial cells |
| RU2491952C2 (ru) * | 2003-07-15 | 2013-09-10 | Бар-Илан Юнивесити | Способы и фармакологические композиции для заживления ран |
| WO2005013885A2 (en) | 2003-08-07 | 2005-02-17 | Healor Ltd. | Pharmaceutical compositions and methods for accelerating wound healing |
| GB0500643D0 (en) * | 2005-01-13 | 2005-02-23 | Renovo Ltd | Medicaments |
| GB0524103D0 (en) | 2005-11-26 | 2006-01-04 | Medical Res Council | Healing |
| WO2008054585A2 (en) | 2006-09-28 | 2008-05-08 | Schering Corporation | Use of pegylated il-10 to treat cancer |
| KR20150072458A (ko) | 2006-11-15 | 2015-06-29 | 코다 테라퓨틱스, 인크. | 상처 치유를 위한 개선 방법 및 조성물 |
| CN101835486B (zh) * | 2007-07-30 | 2012-12-12 | 希尔洛有限公司 | 用于治疗创伤的药物组合物以及相关方法 |
| GB0724231D0 (en) * | 2007-12-12 | 2008-01-30 | Renono Ltd | Methods for inhibiting scarring |
| EP2234656A2 (en) | 2007-12-21 | 2010-10-06 | Coda Therapeutics, Inc. | Improved medical devices |
| WO2009085277A2 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Treatment of abnormal or excessive scars |
| AU2008343840A1 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| BRPI0909374A2 (pt) * | 2008-03-25 | 2015-10-06 | Paloma Pharmaceuticals Inc | métodos para tratar desordens fibróticas |
| JP5888980B2 (ja) | 2008-12-17 | 2016-03-22 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | モノ−およびジ−ｐｅｇｉｌ１０の製造および用途 |
| CN102325789A (zh) * | 2009-02-24 | 2012-01-18 | 希尔洛有限公司 | 用于治疗痤疮和其它病症的内脂素治疗药物 |
| WO2012112791A1 (en) | 2011-02-16 | 2012-08-23 | Paloma Pharmaceuticals, Inc. | Radiation countermeasure agents |
| US20140112898A1 (en) * | 2011-03-31 | 2014-04-24 | President And Fellows Of Harvard College | Unique population of regulatory t cells that regulate tissue regeneration and wound healing |
| CA2873881A1 (en) * | 2012-05-18 | 2013-11-21 | Stephen Bruce Fleming | Combination treatments and compositions for wound healing |
| AU2014254019B2 (en) | 2013-04-18 | 2018-09-27 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| CA2914837A1 (en) | 2013-06-17 | 2014-12-24 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
| US10098929B2 (en) | 2013-08-02 | 2018-10-16 | Children's Hospital Medical Center | Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan |
| US10010588B2 (en) | 2013-08-30 | 2018-07-03 | Armo Biosciences, Inc. | Methods of using pegylated interleukin-10 for treating hyperlipidemia |
| MX2016005915A (es) | 2013-11-11 | 2016-12-16 | Armo Biosciences Inc | Metodos de uso de interleucina-10 para tratar enfermedades y trastornos. |
| US10293043B2 (en) | 2014-06-02 | 2019-05-21 | Armo Biosciences, Inc. | Methods of lowering serum cholesterol |
| CA2958879A1 (en) | 2014-08-22 | 2016-02-25 | Auckland Uniservices Limited | Channel modulators |
| AU2015333827A1 (en) | 2014-10-14 | 2017-04-20 | Armo Biosciences, Inc. | Interleukin-15 compositions and uses thereof |
| ES2941234T3 (es) | 2014-10-22 | 2023-05-19 | Armo Biosciences Inc | Métodos de uso de la interleucina-10 para el tratamiento de enfermedades y trastornos |
| WO2016126615A1 (en) | 2015-02-03 | 2016-08-11 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| AU2016268403A1 (en) | 2015-05-28 | 2017-12-07 | Armo Biosciences, Inc. | Pegylated interleukin-10 for use in treating cancer |
| AU2016312510A1 (en) | 2015-08-25 | 2018-03-08 | Armo Biosciences, Inc. | Methods of using Interleukin-10 for treating diseases and disorders |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4929442A (en) | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
| DE3889479T2 (de) | 1987-02-27 | 1994-12-22 | Eastman Kodak Co | Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung. |
| US5236705A (en) * | 1989-01-20 | 1993-08-17 | The University Of Melbourne | Fibrinolysis |
| US5242902A (en) | 1989-09-06 | 1993-09-07 | The Regents Of The University Of California | Defensin peptide compositions and methods for their use |
| AU635377B2 (en) * | 1989-11-21 | 1993-03-18 | University Of Melbourne, The | Anti-inflammatory compositions and methods |
| AU663050B2 (en) | 1990-04-11 | 1995-09-28 | Brigham And Women's Hospital | Therapeutic uses of actin-binding compounds |
| ATE135233T1 (de) * | 1991-01-10 | 1996-03-15 | Schering Corp | Verwendung von il-4 zur verstärkung von wundheilung und besserung und zur heilung von infizierten wunden und wunden bei diabetischen säugetieren |
| GB9106678D0 (en) | 1991-03-28 | 1991-05-15 | Ferguson Mark W J | Wound healing |
| WO1993004164A1 (en) | 1991-08-26 | 1993-03-04 | THE STATE OF OREGON acting by and through THE STATE OF BOARD OF HIGHER EDUCATION on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY | Keratinocyte-derived conditioned medium as a source of growth factors |
| GB9206861D0 (en) | 1992-03-28 | 1992-05-13 | Univ Manchester | Wound healing and treatment of fibrotic disorders |
| GB9207732D0 (en) * | 1992-04-06 | 1992-05-27 | Isis Innovation | Wound repair |
| WO1994027640A1 (en) * | 1993-05-27 | 1994-12-08 | The Regents Of The University Of Michigan | Method of treatment and prevention of immune complex-induced lung injury |
| HUT73463A (en) | 1993-07-26 | 1996-08-28 | Schering Corp | Agonists and antagonists of human interleukin-10 |
| AU710153B2 (en) * | 1994-03-29 | 1999-09-16 | Renovo Limited | Wound healing |
| EP0793504B1 (en) * | 1994-12-12 | 2005-06-08 | Beth Israel Deaconess Medical Center, Inc. | Chimeric cytokines and uses thereof |
| GB9516012D0 (en) | 1995-08-04 | 1995-10-04 | Univ Manchester | Pharmaceutical composition |
| GB2304045A (en) | 1995-08-04 | 1997-03-12 | Univ Manchester | Betaglycan compositions for promoting the healing of wounds and fibrotic diseases |
-
1995
- 1995-08-09 GB GB9516287A patent/GB2304047A/en not_active Withdrawn
-
1996
- 1996-08-08 EP EP96926507A patent/EP0871473B1/en not_active Expired - Lifetime
- 1996-08-08 DE DE69625516T patent/DE69625516T2/de not_active Expired - Lifetime
- 1996-08-08 ES ES96926507T patent/ES2187665T3/es not_active Expired - Lifetime
- 1996-08-08 DK DK96926507T patent/DK0871473T3/da active
- 1996-08-08 WO PCT/GB1996/001930 patent/WO1997005894A1/en not_active Ceased
- 1996-08-08 JP JP50824697A patent/JP4050317B2/ja not_active Expired - Fee Related
- 1996-08-08 CA CA2229078A patent/CA2229078C/en not_active Expired - Fee Related
- 1996-08-08 ZA ZA9606744A patent/ZA966744B/xx unknown
- 1996-08-08 AT AT96926507T patent/ATE229814T1/de active
- 1996-08-08 US US09/011,027 patent/US6387364B1/en not_active Expired - Lifetime
- 1996-08-08 AU AU66660/96A patent/AU719089B2/en not_active Ceased
- 1996-08-08 PT PT96926507T patent/PT871473E/pt unknown
-
2002
- 2002-02-26 US US10/082,221 patent/US7052684B2/en not_active Expired - Fee Related